Draft:Novonesis

  • Comment: It is OK to have purely offline references, but if that is done there needs to be full details of how to locate the sources. As it happens, at least some of these sources appear to be available online, but not linked into the article correctly, so I would assume this is a mistake of some sort. At the moment it is not possible to assess notability, for companies it is not always easy to get over the notability hurdle, the submitting editor needs to consider WP:NCORP / WP:SIRS. ChrysGalley (talk) 19:50, 19 November 2025 (UTC)
  • Comment: Why do none of the references have links? sus —pythoncoder (talk | contribs) 18:41, 31 October 2025 (UTC)
Novozymes A/S
Novonesis
Company type
Publicly traded Aktieselskab
Nasdaq Nordic: NSIS-B
ISINDK0060336014
IndustryBiotechnology
Predecessor
FoundedJanuary 29, 2024; 2 years ago (2024-01-29)
HeadquartersLyngby, Denmark
ProductsEnzymes, microbiological cultures, biopharmaceutical ingredients, human milk oligosaccharides
Revenue
  • Increase €3,833.5 million
 (2024)
 (2024)
  • Decrease€305.8 million
 (2024)
ParentNovo Holdings A/S
Websitenovonesis.com
Footnotes / references
[1]

Novozymes A/S (doing business as Novonesis)[2] is a biotechnology company headquartered in Lyngby, Denmark. It was established in 2024 following the merger of Novozymes and Chr. Hansen. The company develops enzymes, microbiological cultures, and other biological products used in industries such as food and beverage, agriculture, and energy. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.[3]

History

Novonesis was founded on January 29, 2024, following a merger between Novozymes and Chr. Hansen, two Danish companies specializing in biotechnology.[4][5] The merger was first announced on December 12, 2022[4][6] and would result in Novozymes being the surviving legal entity of the two organizations.[6][2] Press material stated that the name "Novonesis" reflected the combination of "novo," meaning "new" in Latin, and "genesis," meaning "origin" or "beginning."[4]

Novozymes was known for producing industrial enzymes used in applications such as detergents[7], biofuels, and food production.[8] Chr. Hansen specialized in bacterial cultures for use in dairy products, probiotics, and agricultural solutions.[9]

The merger created one of the largest biotechnology companies in Denmark, with a combined product portfolio encompassing enzymes, microbial cultures, and other products for a variety of industries.[5]

In 2025, Novonesis reached an agreement with DSM-Firmenich to acquire its shares of the Feed Enzyme Alliance.[10]

Activities

As of 2024, Novonesis has over 10,000 employees and has activities in over 45 countries.[1] The merged Novonesis has its headquarters in Lyngby[11] but maintains a presence in other locations in Denmark.[4]

Company activities are divided into two divisions: Food and Health Biosolutions and Planetary Health Biosolutions.[1]

Governance and ownership

Novo Holdings A/S, the holding company of the Novo Nordisk Foundation, owns approximately 25% of the company's shares, corresponding to about 65% of its voting rights.[3][12]

See also

References

  1. ^ a b c "Novonesis Annual Report 2024" (PDF). Novonesis. Archived from the original (PDF) on 2025-04-02. Retrieved 2026-02-04.
  2. ^ a b "Vedtægter / Articles of Association" (PDF). Novonesis. 2025-04-03. Retrieved 2026-02-04.
  3. ^ a b "Ownership". Novo Nordisk Fonden. Retrieved 2026-02-04.
  4. ^ a b c d Gelski, Jeff (2024-02-02). "Novonesis emerges from Chr. Hansen-Novozymes merger". Food Business News. Retrieved 2026-02-04.
  5. ^ a b Mommert, Uta (2024-01-29). "Novozymes and Chr. Hansen Complete Merger, Forming Novonesis". European Biotechnology Magazine. Retrieved 2026-02-04.
  6. ^ a b "MERGER PLAN FOR MERGER BETWEEN NOVOZYMES A/S AND CHR. HANSEN HOLDING A/S". power-with-biology.com. Archived from the original on 2024-06-29. Retrieved 2026-02-04.
  7. ^ Yau, Hamish C. L.; Byard, James; Thompson, Lily E.; Malekpour, Adam K.; Robson, Timothy; Bakshani, Cassie R.; Lelanaite, Ieva; Willats, William G. T.; Lant, Neil J. (September 27, 2024). "Enzymatic modification of cotton fibre polysaccharides as an enabler of sustainable laundry detergents". Scientific Reports. 14 (1): 22049. doi:10.1038/s41598-024-73128-x. ISSN 2045-2322.
  8. ^ "The Novozymes history". www.novozymes.com. Archived from the original on 2016-03-08. Retrieved 2026-02-05.
  9. ^ "NASDAQ Company Fact Sheet - Chr. Hansen Holding A/S". NASDAQ Copenhagen. 11 December 2022. Archived from the original on 11 December 2022. Retrieved 4 February 2024.
  10. ^ Jacobsen, Stine (2025-02-11). Solsvik, Terje (ed.). "Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln". Reuters. Retrieved 2026-02-04.
  11. ^ Novonesis. "Don't be a stranger". www.novonesis.com. Archived from the original on 2025-05-17. Retrieved 2026-02-05.
  12. ^ Novonesis. "Stock information". www.novonesis.com. Archived from the original on 2025-05-17. Retrieved 2026-02-04.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.